Mizuho Securities USA

Publicly traded hotel companies beholden to Wall Street
Biotech

Sarepta rewarded by Wall Street for FDA committee shocker

Sarepta's shares skyrocketed Monday after FDA advisers endorsed the risk-benefit profile of the company's DMD gene therapy.
Max Bayer May 15, 2023 11:05am
layoffs cuts workforce reduction

Selecta lays off 25% as unpartnered gene therapies dropped

May 5, 2023 10:45am
photo of the sun breaking through clouds during a sunset

After a year of 'right sizing,' will biotech rebloom in 2023?

Dec 22, 2022 5:00am